Skip to main content

Helix Receives $125K Milestone Payment from Lumera

NEW YORK, Feb. 13 (GenomeWeb News) - Helix BioPharma said last week that it has received a $125,000 milestone payment from Lumera under the terms of a licensing agreement for Helix's heterodimer protein technology.

 

Lumera is currently developing a high-throughput, label-free protein detection platform, which incorporates the Helix technology, through a collaboration with the Institute for Systems Biology.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.